| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/18/2002 | WO2002030965A2 Nucleic acids encoding stichodactylidae chromoproteins |
| 04/18/2002 | WO2002030964A2 Comparative ligand mapping from mhc positive cells |
| 04/18/2002 | WO2002030963A1 Human ect2 and methods of use |
| 04/18/2002 | WO2002030962A2 Metal binding proteins, recombinant host cells and methods |
| 04/18/2002 | WO2002030958A2 Casein peptide fragments with growth-influencing activity on cell cultures |
| 04/18/2002 | WO2002030957A1 Peptide-based gemini surfactant compounds facilitating the transfer into cells |
| 04/18/2002 | WO2002030953A1 Method for modifying a protein structure |
| 04/18/2002 | WO2002030946A1 Specific double-stranded probes for homogeneous detection of nucleic acid and their application methods |
| 04/18/2002 | WO2002030945A2 Concatenated nucleic acid sequences |
| 04/18/2002 | WO2002030944A2 Fluorescent nucleobase conjugates having anionic linkers |
| 04/18/2002 | WO2002030561A2 Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof |
| 04/18/2002 | WO2002030471A2 A novel system for the evaluation of the activity and/or specificity of a viral component |
| 04/18/2002 | WO2002030470A1 Methods and compositions for nucleic acid delivery |
| 04/18/2002 | WO2002030468A1 Complexes for transferring nucleic acids into cells |
| 04/18/2002 | WO2002030465A2 Compositions that inhibit proliferation of cancer cells |
| 04/18/2002 | WO2002030462A2 Hedgehog antagonists, methods and uses related thereto |
| 04/18/2002 | WO2002030435A1 Treatment of t cell disorders |
| 04/18/2002 | WO2002030268A2 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer |
| 04/18/2002 | WO2002030256A2 Diagnostic indicator of thymic function |
| 04/18/2002 | WO2002030205A2 Treatment of transgenic corn seeds with pesticides |
| 04/18/2002 | WO2002030185A1 Animal showing schizophrenia-like abnormality in cognitive behaviors and method of constructing the same |
| 04/18/2002 | WO2002030184A1 Modulating cytokine or hormone signalling in an animal comprising up-regulating the expression of socs sequence in the animal |
| 04/18/2002 | WO2002030183A1 Genetic control of sex ratio in animal populations |
| 04/18/2002 | WO2002014499A9 Claudin polypeptides |
| 04/18/2002 | WO2002012483B1 Promoters of plant defence-associated genes |
| 04/18/2002 | WO2002010356A3 Novel amylolytic enzyme extracted from bacillus sp. a 7-7 (dsm 12368) and washing and cleaning agents containing this novel amylolytic enzyme |
| 04/18/2002 | WO2002010334A3 Dna element promoter of transcription activity, active in human cells and general method for adjusting the activity thereof |
| 04/18/2002 | WO2002010207A3 Proton-translocating retinal protein |
| 04/18/2002 | WO2002008272A3 High affinity soluble interleukin-18 receptor |
| 04/18/2002 | WO2002008252A3 Novel protein containing ring finger domaine r1p4 |
| 04/18/2002 | WO2002006478A3 Extracellular matrix protein |
| 04/18/2002 | WO2002004007A3 Stable (fixed) forms of viral capsid proteins, fusion proteins and uses thereof |
| 04/18/2002 | WO2002001949A3 Transgenic mouse for screening and for studies of the pharmacodynamics and pharmacokinetics of ligands acting on the oestrogen receptor and its intracellular receptors, and method for the preparation thereof |
| 04/18/2002 | WO2002000914A3 Bioengineered vehicles for targeted nucleic acid delivery |
| 04/18/2002 | WO2002000834A3 A novel polypeptide--human protein phosphatase 9.68 and the polynucleotide |
| 04/18/2002 | WO2002000832A3 A novel polypeptide--a p80-coilin protein 8.8 and the polynucleotide encoding this novel polypeptide |
| 04/18/2002 | WO2001098479A3 Plant resistance gene |
| 04/18/2002 | WO2001094573A3 Processing of plasmid-containing fluids |
| 04/18/2002 | WO2001094542A3 Algorithmic determination of connectrons |
| 04/18/2002 | WO2001093902A3 Immunostimulatory rna/dna hybrid molecules |
| 04/18/2002 | WO2001089729A3 Compositions and methods for microbial dechlorination of polychlorinated biphenyl compounds |
| 04/18/2002 | WO2001088141A3 Synthetic gagpol genes and their uses |
| 04/18/2002 | WO2001085954A3 Serine-threonine kinase-3 |
| 04/18/2002 | WO2001085766A3 Novel eosinophil cationic proteins used in the treatment of asthmatic and allergic disorders |
| 04/18/2002 | WO2001083744A3 Natrium-calcium exchanger protein |
| 04/18/2002 | WO2001083721A3 32132, a novel fucosyltransferase family member and uses therefor |
| 04/18/2002 | WO2001081596A3 Methods for enhancing the expression of a protein of interest by recombinant host cells |
| 04/18/2002 | WO2001081579A8 Anti-idiotype inducing antibodies, comprising at least one epitope from angiogenin, for the inhibition of angiogenesis |
| 04/18/2002 | WO2001081574A3 Regulation of nf-at interacting protein nip 45 variant |
| 04/18/2002 | WO2001081559A3 26335, a novel human serine/threonine dehydratase and uses thereof |
| 04/18/2002 | WO2001081409A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 04/18/2002 | WO2001079514A3 Amino acid:glyoxylate aminotransferase genes from plants and uses thereof |
| 04/18/2002 | WO2001079441A8 Gene inactivation by targeted dna methylation |
| 04/18/2002 | WO2001077357A3 Chromosomal vectors and uses thereof |
| 04/18/2002 | WO2001077177A8 Gpcr-proteins and nucleic acids encoding same |
| 04/18/2002 | WO2001075091A3 A method for in vitro molecular evolution of antibody function |
| 04/18/2002 | WO2001075052A3 A novel polypeptide, nadh dehydrogenase human sub-unit i-17 and the polynucleotide encoding the polypeptide |
| 04/18/2002 | WO2001073037A3 R5 protein, a cell-surface protective antigen of group b streptococci |
| 04/18/2002 | WO2001072955A3 Regulation of human nedd1-related protein |
| 04/18/2002 | WO2001072777A3 Human transcription factors |
| 04/18/2002 | WO2001070985A3 Bi-functional cancer treatment agents |
| 04/18/2002 | WO2001070980A3 Isolated g-protein coupled receptors, nucleic acid molecules encoding gpcr proteins, and uses thereof as insecticidal targets |
| 04/18/2002 | WO2001070954A3 Regulation of human nerve growth factor-elated g protein-coupled receptor |
| 04/18/2002 | WO2001070247A3 Salmonella vaccine materials and methods |
| 04/18/2002 | WO2001068912A3 Diagnosis of diseases associated with tumor suppressor genes and oncogenes |
| 04/18/2002 | WO2001066803A3 Phytomics: a genomic-based approach to herbal compositions |
| 04/18/2002 | WO2001066765A3 26583, a serine/threonine phosphatase and uses thereof |
| 04/18/2002 | WO2001066764A3 16835, a human phospholipase c and uses thereof |
| 04/18/2002 | WO2001066717A8 Gene targeting method |
| 04/18/2002 | WO2001066712A3 Variants with altered properties |
| 04/18/2002 | WO2001066595A3 Human fgf-23 gene and gene expression products |
| 04/18/2002 | WO2001064913A3 Cell cycle proteins associated with rad9, compositions and methods of use |
| 04/18/2002 | WO2001064911A3 18232, a dual specificity phosphatase |
| 04/18/2002 | WO2001064876A3 Human schizophrenia gene |
| 04/18/2002 | WO2001064856A3 Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding |
| 04/18/2002 | WO2001063284A3 Internal standards and controls for multiplexed assay |
| 04/18/2002 | WO2001062918A3 Secretory polypeptides and corresponding polynucleotides |
| 04/18/2002 | WO2001061007A9 Fibroblast growth factor-23 molecules and uses thereof |
| 04/18/2002 | WO2001060152A3 Transgenic non-human ucp2 knockout mammal |
| 04/18/2002 | WO2001059087A3 Compositions for transfecting nucleic acids and their use |
| 04/18/2002 | WO2001058916A3 Antibodies to ccr5 |
| 04/18/2002 | WO2001057257A3 Isolation and identification of mrnas correlating to secreted proteins |
| 04/18/2002 | WO2001057215A3 Human g-protein coupled receptor polypeptides and polynucleotides having homology with odorant receptors |
| 04/18/2002 | WO2001057073A3 Infectious cdna clone of hepatitis e virus (hev) genome, its production and uses |
| 04/18/2002 | WO2001055433A3 Tissue-specific expression of target genes in plants |
| 04/18/2002 | WO2001055214A3 Asthma-associated gene |
| 04/18/2002 | WO2001053306A3 Manufacture of five-carbon sugars and sugar alcohols |
| 04/18/2002 | WO2001051632A3 Odorant receptor polypeptides and nucleic acids encoding same |
| 04/18/2002 | WO2001051631A3 Regulatory sequence for the specific expression in dendritic cells and uses thereof |
| 04/18/2002 | WO2001051520A3 Nogo receptor-mediated blockade of axonal growth |
| 04/18/2002 | WO2001051080A3 Methods and compositions for obtaining disease protection for animals |
| 04/18/2002 | WO2001049712A3 Vaccine against isav (infectious salmon anaemia virus) |
| 04/18/2002 | WO2001046447A3 Method to improve drought tolerance in plants |
| 04/18/2002 | WO2001046226A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 04/18/2002 | WO2001040271A3 Cancer associated antigens and uses therefor |
| 04/18/2002 | WO2001036464A3 SUNFLOWER RhoGAP, LOX, ADH, AND SCIP-1 POLYNUCLEOTIDES AND METHODS OF USE |
| 04/18/2002 | WO2001034789A3 Computational method for inferring elements of gene regulatory network from temporal patterns of gene expression |
| 04/18/2002 | WO2001032684A3 Method for linking molecular substances based on the affinity of the proline-rich amino acid sequences and protein domains of type ww |
| 04/18/2002 | WO2001031060A3 Identical-by-descent fragment enrichment |
| 04/18/2002 | WO2001027324A3 Converting diploidy to haploidy for genetic diagnosis |